Neha Jodhawat: Advancing Precision Medicine in Immune Thrombocytopenia at ISTH 2026
Neha Jodhawat, PhD scholar at ICMR-National Institute of Immunohaematology, shared a post on LinkedIn:
“Winding up the ISTH 2026, Paris !
I am delighted to share that I had an opportunity to present my work at the ISTH ‘Immune and genetic profiling as step toward precision medicine in pediatric immune thrombocytopenia’ !!
Thank you to Anusandhan National Research Foundation (ANRF) for giving me international Travel support, which enabled me to attend International Society on Thrombosis and Haemostasis (ISTH) , held from 11-15 July 2026 in Paris,France.
The conference was an excellent opportunity to interact with leading researchers in the field of Immune thrombocytopenia.
I would also like to thank my supervisor and Director Manisha Madkaikar and my institute ICMR-National Institute for Research on Blood and Immune Disorders, (ICMR-NIRBID) for their constant guidance and encouragement throughout!
Thankful and grateful!!”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question